Jabra Enhance Select 200 vs Phonak Audeo R Infinio 90
Side-by-side HearAdvisor lab results with SoundGrades, expert pick badges, and the same visualizations we use in product reviews.

Jabra Enhance Select 200
The Jabra Enhance Select 200 is a premium-priced OTC hearing aid that earned a B grade with a SoundScore of 3.9/5 in our lab testing, placing it in the top 35% of the OTC hearing aid category. At $1,695, this behind-the-ear device offers solid performance in several key areas, though it faces stiff competition from higher-scoring alternatives at similar price points. In our testing, this device showed particular strength in speech clarity during quiet listening situations, scoring 3.5/5—0.67 points above the category average. Own-voice comfort was another highlight at 3.4/5, finishing 0.89 points above average, which suggests users may find their own voice sounds more natural compared to many competitors. Music streaming scored 2.6/5, which is above the category average by 0.68 points but still only mixed in absolute terms. The device's limitations become apparent in challenging listening environments. Speech in noise scored just 1.4/5, slightly below the category average and low in absolute terms—a consideration for users who frequently encounter noisy restaurants or social gatherings. Feedback handling scored 4.0/5, which is strong in absolute terms though 0.54 points below the category average. The Enhance Select 200 has earned Expert's Choice Awards in both 2023 and 2024, reflecting its reliable real-world performance. With Bluetooth streaming for both iPhone and Android, rechargeable batteries, and hands-free capability, it offers modern convenience features. However, shoppers should note that several competitors in this price range—including the Lucid Tala and Audicus Omni 2—scored notably higher in our testing. This device is best suited for users who prioritize speech clarity in quieter environments and own-voice comfort over performance in noisy situations.
Choice

Phonak Audeo R Infinio 90
The Phonak Audeo R Infinio 90 is a premium prescription behind-the-ear hearing aid released in 2024, priced at $4,996. In our lab testing, it earned an A grade with a SoundScore of 4.4/5, ranking #18 among 39 prescription hearing aids tested. Speech clarity is a standout strength in our testing. Speech in quiet scored 4.4/5, a strong result that sits 1.01 points above the category average. Speech in noise performance is more mixed at 2.5/5—above the category average by 0.37 points, but only moderate in absolute terms. This pattern suggests the Infinio 90 excels in calmer listening environments while offering incremental benefits in challenging noise. Streaming music quality impressed at 4.0/5, a strong score that lands 1.24 points above category average. Feedback handling scored 4.2/5, which is strong in absolute terms though 0.52 points below the category average. Own-voice comfort was mixed at 2.2/5, falling 0.50 points below average—something to discuss with your hearing care provider if natural voice quality is a priority. The Infinio 90 competes in a crowded premium segment. At this price point, alternatives like the Phonak Sphere Infinio (4.98/5) and Oticon Intent (4.83/5) achieved higher overall scores in our testing. Buyers seeking Phonak's ecosystem and strong speech-in-quiet performance may find the Infinio 90 appealing, though those prioritizing noise performance or own-voice comfort should compare options carefully with their provider.
Performance metrics
Scale 1-5 (Tuned)
Lab metric by fit
Scale 1-5 (Tuned)
Speech level
Adjust input dB (Tuned)
Amplification (REIG)
Insertion gain at 65 dB (Tuned)
Fitting configuration for tuned fit